In contrast, administration of semaglutide in doses of 150 and 300 mcg/kg attenuated this downregulation of GLP-1R mRNA expression and showed an increase in GLP-1R expression by 2.99-fold and 4.24-fold, respectively, compared to the osteoporotic group as seen in Fig
(ref) Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, Pavlov KH, Petrovic A, Sikiric S, Vranes H, Prtoric A, Zizek H, Durasin T, Dobric I, Staresinic M, Strbe S, Knezevic M, Sola M, Kokot A, Sever M, Lovric E, Skrtic A, Blagaic AB, Sikiric P
Go Bland and Lean at First
as such, it provides a positive effect on lipid metabolism and insulin sensitivity without the side effects caused by PPAR activation
Teva received the first FDA approval for a generic GLP-1 in August